Literature DB >> 8375249

Painful neuropathy and foot ulceration in diabetic patients.

A Veves1, C Manes, H J Murray, M J Young, A J Boulton.   

Abstract

OBJECTIVE: To examine the prevalence of painful symptoms in neuropathic patients with or without foot ulceration. It has been suggested that there are two clinical presentations of sensory diabetic neuropathy with little overlap: painful (acute or chronic) and painless with recurrent foot ulceration. RESEARCH DESIGN AND METHODS: We examined three groups of diabetic patients matched for age and duration of diabetes--24 without neuropathy on clinical grounds (mean age 56.1 yr [range 38-76 yr], diabetes duration 12.6 yr [0.4-40 yr]), 30 with neuropathy (mean age 55.3 yr [range 21-73 yr], diabetes duration 17.3 yr [range 0.2-61 yr]), and 40 with neuropathic foot ulceration (mean age 58.1 yr [range 41-72 yr], diabetes duration 18.5 yr [range 1-46 yr])--and compared them with 20 healthy subjects (mean age 50 yr [range 37-69 yr]). For evaluation of neuropathy, the neuropathy symptom score, neuropathy disability score, and vibration perception threshold were measured.
RESULTS: No difference existed between the neuropathic and foot ulcer groups in the neuropathy symptom score (4.2 +/- 3.9 [mean +/- SD] vs. 2.5 +/- 2.1, NS) and neuropathy disability score (15.1 +/- 5.7 vs. 16.8 +/- 6.1, NS), but the vibration perception threshold was lower in the neuropathic group (30.1 +/- 13.4 vs. 40.5 +/- 13.8 V, P < 0.001). Painful symptoms (neuropathy symptom score > 3), either in the past or during the time the study was conducted, had been experienced by none of the control subjects, 7 (29%) of the nonneuropathic group, 18 (60%) of the neuropathic group, and 17 (43%) of the foot ulcer group (NS for the last two groups), and were present at the time of examination in 13 (43%) of the neuropathic group and in 13 (33%) of the foot ulcer group (NS in all groups). Duration of symptoms was < 12 mo in 12 (40%) neuropathic and 15 (38%) foot ulcer patients (NS).
CONCLUSIONS: We conclude that painful symptoms are frequent in diabetic neuropathy, irrespective of the presence or absence of foot ulceration and that these symptoms can occur at any stage of the disease. These results suggest that there is a spectrum of neuropathic syndromes from the painful to the patients with foot ulceration, and that much overlap exists.

Entities:  

Mesh:

Year:  1993        PMID: 8375249     DOI: 10.2337/diacare.16.8.1187

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

1.  Operative Intervention Does Not Change Pain Perception in Patients With Diabetic Foot Ulcers.

Authors:  Olivia V Waldman; Stephanie P Hao; Jeff R Houck; Nicolette J Lee; Judith F Baumhauer; Irvin Oh
Journal:  Clin Diabetes       Date:  2020-04

2.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

3.  In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment.

Authors:  Jiang Ouyang; Xiaoyuan Ji; Xingcai Zhang; Chan Feng; Zhongmin Tang; Na Kong; Angel Xie; Junqing Wang; Xinbing Sui; Liu Deng; Younian Liu; Jong Seung Kim; Yihai Cao; Wei Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

Review 4.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

5.  Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology.

Authors:  Christopher H Gibbons; Roy Freeman; Aristidis Veves
Journal:  Diabetes Care       Date:  2010-08-30       Impact factor: 19.112

Review 6.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

7.  Treatment of hyperesthetic neuropathic pain in diabetics. Decompression of the tarsal tunnel.

Authors:  T J Wieman; V G Patel
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

Review 8.  Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities.

Authors:  Noha Amin; John Doupis
Journal:  World J Diabetes       Date:  2016-04-10

9.  The evolving natural history of neurophysiologic function in patients with well-controlled diabetes.

Authors:  Christopher H Gibbons; Roy Freeman; Francisco Tecilazich; Thanh Dinh; Thomas E Lyons; Charalambos Gnardellis; Aristidis Veves
Journal:  J Peripher Nerv Syst       Date:  2013-06       Impact factor: 3.494

10.  Comparison of shoe-length fit between people with and without diabetic peripheral neuropathy: a case-control study.

Authors:  Alistair D McInnes; Farina Hashmi; Lisa J Farndon; Amanda Church; Maria Haley; Debora M Sanger; Wesley Vernon
Journal:  J Foot Ankle Res       Date:  2012-04-16       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.